RootsAnalysishas announced the addition of “BiopharmaceuticalCROs Market, 2021-2030,” report toits list of offerings.
Given theirnumerous advantages, which include high specificity for intended moleculartargets, ability to treat a myriad of disease indications, and patient friendlytoxicity profiles, the demand for biologics is high and growing. This presents lucrativeopportunities for contract research providers that offer services for thisrapidly evolving class of pharmacological interventions. In fact, since 2001,over 80 new CROs have been established, offering a wide variety ofcost-efficient research services and solutions to biologic developers.
To order this 235+ page report, which features 120+ figuresand 110+ tables, please visit this https://www.rootsanalysis.com/reports/biopharmaceutical-cros-market.html
Key Market Insights
More than 160 players claim to offer contract researchservices to pharmaceutical and biotechnology companies across the world
Thissegment of the service industry is dominated by start-ups / small companies (2-50employees) and mid-sized players (51-200 employees), which representmore than 70% of the contemporary CRO landscape. Close to 50% of thestakeholders are based in North America, followed by Europe and theAsia-Pacific region.
More than 45% of companies claim to offer research servicesfor vaccines and cell therapies
On the other hand,close to 40% of CROs claim to have the required capabilities to provideantibody related research services. A number of biopharmaceutical research serviceproviders are now offering services for niche and upcoming classes ofbiologics, such as Altasciences, Biocon, and Iris Pharma.
Since 2016, more than 70+ partnerships have been inkedbetween CROs and industry stakeholders, worldwide
Interestingly,the maximum number of partnership agreements were inked in 2020, majority ofwhich were acquisitions (34%), followed by clinical trial agreements (28%). Itis worth noting that the partnership activity within this domain has increasedat a CAGR of 55%, between 2016 and 2021.
To request a sample copy / brochure of this report, pleasevisit this
https://www.rootsanalysis.com/reports/biopharmaceutical-cros-market/request-sample.html
Key Questions Answered
§ Who are the keyplayers offering contract research services for biopharmaceuticals?
§ Which kind ofbusiness models are commonly adopted by biopharmaceutical companies whileoutsourcing their R&D and clinical research operations?
§ What kind ofpartnership models are commonly adopted by stakeholders in this industry?
§ What are the keyvalue drivers of the merger and acquisition activity within this domain?
§ How is the currentand future market opportunity likely to be distributed across key marketsegments?
§ What are theanticipated future trends within the biopharmaceutical contract researchservices market?
TheUSD 67 billion (by 2030) financial opportunity within the biopharmaceutical contract researchservice providers market has been analyzed across the following segments:
§ Geography
§ North America
§ Europe
§ Asia-Pacific
§ MENA
§ Latin America
§ Therapeutic Area
§ Oncological Disorder
§ Neurological Disorder
§ Infectious Disorder
§ Autoimmune Disorder
§ Cardiovascular Disorder
§ Respiratory Disorder
§ Others
§ Biologics
§ Antibody
§ Cell Therapy
§ Gene Therapy
§ Vaccine
§ Recombinant Protein
§ Others
§ End-user
§ Small
§ Mid-sized
§ Very large / large
Theresearch includes detailed profiles of key service providers (listed below)engaged in this domain; each profile features an overviewof the company, information related to its biologics focused service portfolio,recent developments, and an informed future outlook.
§ Biocon
§ Covance
§ ICON
§ Medpace
§ Phamaron
§ PPD
§ PRA Health Sciences
§ Syneos Health
§ Vimta Labs
§ WuXi AppTec
Foradditional details, please visit
https://www.rootsanalysis.com/reports/biopharmaceutical-cros-market.htmlor email sales@rootsanalysis.com
Youmay also be interested in the following titles:
1. Top Selling BiologicsMarket, 2021-2030
2. Celland Gene Therapy CROs Market (2nd Edition), 2021-2030
3. BiopharmaceuticalContract Manufacturing Market (4th Edition), 2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
